Qiagen Is Said to Consider Strategic Options Amid Fresh Interest
Qiagen NV, the European molecular testing firm, is weighing strategic options including a potential sale amid fresh takeover interest, people with knowledge of the matter said.
By Eyk Henning, Dinesh Nair, David Carnevali, Michelle F Davis · Bloomberg
Qiagen NV, the European molecular testing firm, is weighing strategic options including a potential sale amid fresh takeover interest, people with knowledge of the matter said.